Amarin Announces Results from Exploratory Phase 2a Study of EN101 in – Businesswire.com
DUBLIN–( BUSINESS WIRE )–Amarin Corporation plc (NASDAQ:AMRN) today announced encouraging top line results from an exploratory Phase 2a multi-centre, dose-ranging, cross-over clinical study of EN101 in patients with myasthenia gravis, a chronic

Get Social, Bookmark Us!!:
  • blinkbits
  • BlinkList
  • blogmarks
  • co.mments
  • del.icio.us
  • digg
  • Fark
  • Furl
  • Ma.gnolia
  • NewsVine
  • Reddit
  • Smarking
  • Spurl

Related posts:

  1. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its – PR Newswire
  2. New Study Spurs Concern About Chemical in IV Bags – Wall Street Journal
  3. Sequenom Announces New Positive Data on Down Syndrome Detection and – PR Inside
  4. DiaMedica Cleared to Initiate Its Second Phase II Clinical Trial … – MSNBC
  5. AstraZeneca submits sNDA for NEXIUM (esomeprazole magnesium) – News-Medical.Net
  6. Additional Phase II Data Demonstrate Improvement In Reported Symptoms – Medical News Today

You must be logged in to post a comment.

Posts

Former Severe Acid Reflux Sufferer Reveals The Only Holistic System In Existence That Will Show You How To Permanently Cure Your Acid Reflux, Achieve Lasting Freedom From Most Digestive Disorders and Regain Your Natural Inner Balance Using A Unique 5-Step Method No One Else Will Tell You About

 If you would like to learn how to cure your acid reflux and heartburn permanently ... without drugs, without antacids, and without any side effects, then this will be the most important information you will ever read. I guarantee it and I've got the results to prove it!


Get It Right Now
Click the LInk Below